医薬品連続生産のヨーロッパ市場2020-2162

◆英語タイトル:EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2020-2028
◆商品コード:INK20MY213
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年4月
◆ページ数:114
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:ヨーロッパ
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥131,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥157,500見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥210,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGSThe Europe pharmaceutical continuous manufacturing market is evaluated to reach a CAGR of 9.11% during the estimated period of 2020-2028. The factors impacting market growth in the region are the presence of developed infrastructure in pharmaceutical industries, the availability of trained professionals to handle complex manufacturing systems, and a strong presence of major players.

MARKET INSIGHTS
The Europe pharmaceutical continuous manufacturing market is analyzed further by dividing the region into Russia, the UK, Poland, France, Germany, Belgium, Italy, and the rest of Europe that includes Sweden, Switzerland, Denmark, Netherlands, and others. In Russia, the market is in its developing stage. Russian medicines accounted for about 20% of the market in 2009, and by the end of 2017, Russian drugs accounted for more than 30% of the market. Belgium is a global leader in the pharmaceutical industry, employing around 30,000 workers, and this number is increasing every year. Pharmaceuticals attribute more than 10% of Belgium’s total exports, and there is a heavy investment by the government and the pharmaceutical industry to develop this sector further, along with R&D.
Poland is among the largest markets in Central and Eastern Europe. There is a growing awareness among people about health issues, disease prevention, and willing to pay for high-quality pharmaceuticals in Poland. The pharmaceutical market in the country is regulated by a number of legalities. The market is developing at a steady rate in Poland. In the rest of European countries, the increasing consumer awareness, coupled with growing income and desire for convenience, rising demand for pharmacy products, growing geriatric population, and the increased adoption of pharmaceutical continuous manufacturing,s are driving the market growth.

COMPETITIVE INSIGHTS
Gebruder Lodige Maschinenbau GmbH, Coperion GmbH, Korsch, GEA Group, Glatt GmbH, etc. are some of the eminnt players in the market.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. INCREASED ADOPTION OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS
3.2.2. RISING GOVERNMENTS INITIATIVES FOR THE ADOPTION OF CONTINUOUS MANUFACTURING SYSTEMS
3.3. KEY RESTRAINTS
3.3.1. INCREASING CUSTOMER ANTICIPATIONS
4. KEY ANALYTICS
4.1. PORTER’S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER’S POWER
4.1.4. SUPPLIER’S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. REGULATORY FRAMEWORK
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. KEY INVESTMENT INSIGHTS
5. MARKET BY PRODUCT
5.1. INTEGRATED CONTINUOUS SYSTEM
5.2. SEMI-CONTINUOUS SYSTEM
5.3. CONTROL & SOFTWARE
6. MARKET BY APPLICATION
6.1. FINAL DRUG PRODUCT MANUFACTURING
6.2. API MANUFACTURING
7. MARKET BY END-USER
7.1. PHARMACEUTICAL COMPANIES
7.2. CONTRACT MANUFACTURING ORGANIZATIONS
7.3. OTHER END-USERS
8. GEOGRAPHICAL ANALYSIS
8.1. EUROPE
8.1.1. THE UNITED KINGDOM
8.1.2. FRANCE
8.1.3. GERMANY
8.1.4. ITALY
8.1.5. RUSSIA
8.1.6. BELGIUM
8.1.7. POLAND
8.1.8. REST OF EUROPE
9. COMPANY PROFILES
9.1. COPERION GMBH
9.2. ELI LILLY & COMPANY
9.3. GEA GROUP AG
9.4. GEBRUDER LODIGE MASCHINENBAU GMBH
9.5. GLATT GMBH
9.6. HOSOKAWA MICRON CORPORATION
9.7. KORSCH AG
9.8. L.B. BOHLE MASCHINEN + VERFAHREN GMBH
9.9. MUNSON MACHINERY COMPANY
9.10. PFIZER INC
9.11. SIEMENS HEALTHINEERS
9.12. SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)
9.13. THERMO FISHER SCIENTIFIC INC



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[医薬品連続生産のヨーロッパ市場2020-2162]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆